Procainamide Hydrochloride
PROCAINAMIDE HYDROCHLORIDE
46 matching records for Procainamide.
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
PROCAINAMIDE HCI
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
Procainamide Hydrochloride
procainamide hydrochloride
PROCAINAMIDE HYDROCHLORIDE
PROCAINAMIDE HCI
procainamide hydrochloride
PROCAINAMIDE HYDROCHLORIDE
Procainamide Hydrochloride
Procainamide Hydrochloride
20260209
20251202
20251028
20250711
20250217
20241218
20240723
20240219
20231121
20230424
20190731
20180813
20180406
2025-10-01
2025-08-31
15 mapped labels
A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the cardiovascular drug procainamide in a clinical specimen, using an enzyme immunoassay (EIA) method.
A collection of reagents and other associated materials intended to be used for the quantitative detection of N-acetyl procainamide (NAPA) in a clinical specimen, using a nephelometry/turbidimetry method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of the cardiovascular drug procainamide in a clinical specimen, using a nephelometry/turbidimetry method.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of N-acetyl procainamide (NAPA) in a clinical specimen, using a fluorescent immunoassay method.
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement of N-acetyl procainamide (NAPA) in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the quantitative measurement and therapeutic monitoring of the cardiovascular drug procainamide in a clinical specimen.